Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699374011 | Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3700158019 | Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 5074230010 | Product containing precisely salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Salmeterol only product in pulmonary dose form | true | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Some | 1 | |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has BoSS | Salmeterol | true | Inferred relationship | Some | 1 | |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has manufactured dose form | Pressurised suspension for inhalation | true | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Salmeterol-containing product | false | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Is a | Product manufactured as pulmonary dose form | false | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has unit of presentation | Actuation | true | Inferred relationship | Some | ||
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Has precise active ingredient | Salmeterol xinafoate | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR